UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Relugolix Combination Improves Quality of Life in Phase 3 Studies of Symptomatic Uterine Fibroids [OP04-4D]

Obstetrics and gynecology (New York. 1953), 2020-05, Vol.135 (1), p.7-7S

2020

Volltextzugriff (PDF)

Transcervical Radiofrequency Ablation of Uterine Fibroids: US Experience From the SONATA Pivotal IDE Trial [22J]

Obstetrics and gynecology (New York. 1953), 2019-05, Vol.133 (1), p.113-113S

2019

Volltextzugriff (PDF)

Relugolix Combination Therapy Reduced Uterine Fibroid-Associated Pain in Two Phase 3 LIBERTY Studies [32B]

Obstetrics and gynecology (New York. 1953), 2020-05, Vol.135 (1), p.27-27S

2020

Volltextzugriff (PDF)

Health-related Quality of Life With Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial

Obstetrical & gynecological survey, 2019-08, Vol.74 (8), p.471-472

2019

Volltextzugriff (PDF)

LIBERTY: LONG-TERM EXTENSION STUDY DEMONSTRATING ONE-YEAR EFFICACY AND SAFETY OF RELUGOLIX COMBINATION THERAPY IN WOMEN WITH SYMPTOMATIC UTERINE FIBROIDS

Fertility and sterility, 2020-09, Vol.114 (3), p.e1-e1

2020

Volltextzugriff (PDF)

A Benefit-Risk Review of Systemic Haemostatic Agents: Part 2: In Excessive or Heavy Menstrual Bleeding

Drug safety, 2008, Vol.31 (4), p.275-282

2008

Volltextzugriff (PDF)

Bleeding Patterns in Women With Uterine Fibroids Receiving Relugolix Combination Therapy Over 1 Year [A78]

Obstetrics and gynecology (New York. 1953), 2022-05, Vol.139 (1), p.23-23S

2022

Volltextzugriff (PDF)

Relugolix Combination Therapy Improves Uterine Fibroid Symptoms Independent of Fibroid Location [A77]

Obstetrics and gynecology (New York. 1953), 2022-05, Vol.139 (1), p.23-23S

2022

Volltextzugriff (PDF)

RELUGOLIX COMBINATION THERAPY SIGNIFICANTLY REDUCED MENSTRUAL BLOOD LOSS WITH FIRST TREATMENT CYCLE IN WOMEN WITH HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS: RESULTS FROM THE LIBERTY PHASE 3 PROGRAM

Fertility and sterility, 2020-09, Vol.114 (3), p.e85-e85

2020

Volltextzugriff (PDF)

LIBERTY RANDOMIZED WITHDRAWAL STUDY: 2-YEAR EFFICACY AND SAFETY OF RELUGOLIX COMBINATION THERAPY IN WOMEN WITH HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS

Fertility and sterility, 2021-09, Vol.116 (3), p.e2-e2

2021

Volltextzugriff (PDF)

EFFECTS OF RELUGOLIX COMBINATION THERAPY ON BONE MINERAL DENSITY THROUGH 2 YEARS IN WOMEN WITH HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS

Fertility and sterility, 2021-09, Vol.116 (3), p.e13-e13

2021

Volltextzugriff (PDF)

Spherical Ball-Shaped Intrauterine Device Long-Acting Reversible Contraception: Post-marketing Pharmacovigilance Assessment

European Medical Journal. Reproductive health, 2023-07, p.2-10

2023

Volltextzugriff (PDF)

TIME TO MINIMAL OR NO PELVIC PAIN WITH RELUGOLIX COMBINATION THERAPY IN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN: RESULTS FROM THE SPIRIT PROGRAM

Fertility and sterility, 2022-10, Vol.118 (4), p.e6-e7

2022

Volltextzugriff (PDF)

RELUGOLIX COMBINATION THERAPY IMPROVES UTERINE FIBROID-ASSOCIATED PAIN DURING MENSTRUAL AND NON-MENSTRUAL DAYS: RESULTS FROM THE LIBERTY PHASE 3 PROGRAM

Fertility and sterility, 2020-09, Vol.114 (3), p.e232-e232

2020

Volltextzugriff (PDF)

Treatment of symptoms of uterine fibroids with relugolix combination therapy: efficacy and safety results from the phase 3 liberty 1 clinical trial

Fertility and sterility, 2019-09, Vol.112 (3), p.e434-e434

2019

Volltextzugriff (PDF)

Ulipristal Acetate Impact on Fibroid Volume: Integrated Results From VENUS I and II [11Q]

Obstetrics and gynecology (New York. 1953), 2018-05, Vol.131 (1), p.187-187S

2018

Volltextzugriff (PDF)

Potential clinical applications of uterine artery occlusion

Expert Review of Obstetrics & Gynecology, 2009-09, Vol.4 (5), p.533-546

2009

Volltextzugriff (PDF)

Treatment of uterine fibroid symptoms with relugolix combination therapy

Reproductive health of woman (Online), 2024-05 (4), p.53-62

2024

Volltextzugriff (PDF)

Tranexamic Acid Treatment for Heavy Menstrual Bleeding: A Randomized Controlled Trial

Obstetrics and gynecology (New York. 1953), 2011-01, Vol.117 (1), p.176-177

2011

Volltextzugriff (PDF)

Advantages wth Using the Levonorgestrel-Releasing Intrauterine System in Females with Hemostatic Disorders

Blood, 2006-11, Vol.108 (11), p.3303-3303

2006

Volltextzugriff (PDF)

How effective is elagolix treatment in women with fibroids and HMB?

OBG Management, 2020-07, Vol.32 (7)

Lukes, Andrea S

2020

Volltextzugriff (PDF)

Screening Tool for Bleeding Disorders in Women with Menorrhagia: Evaluation in a Prospective US Multi-Site Cohort

Blood, 2008-11, Vol.112 (11), p.1237-1237

2008

Volltextzugriff (PDF)

Assessment of Procedure Tolerability During Her Option Endometrial Ablation in Out-Patient Settings

Obstetrics and gynecology (New York. 1953), 2006-04, Vol.107 (Supplement), p.58-59S

2006

Volltextzugriff (PDF)

A Multi-Site, Prospective Cross-Over Study of Intranasal Desmopressin and Oral Tranexamic Acid in Women with Menorrhagia and Abnormal Laboratory Hemostasis

Blood, 2007-11, Vol.110 (11), p.711-711

2007

Volltextzugriff (PDF)

Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks

The Journal of steroid biochemistry and molecular biology, 2016-05, Vol.159, p.142-153

2016

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(39)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(11)
Physical Sciences
(8)
Humans
(6)
Chemistry
(5)
Female
(5)
Chemistry, Physical
(4)
Physics
(4)
Adult
(3)
Male
(3)
Multidisciplinary Sciences
(3)
Physics, Atomic, Molecular & Chemical
(3)
Science & Technology - Other Topics
(3)
Aged
(2)
Cohort Studies
(2)
Computer Science
(2)
Dft
(2)
Engineering
(2)
Engineering, Multidisciplinary
(2)
Flavonoid
(2)
Genotype
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Relugolix Combination Improves Quality of Life in Phase 3 Studies of Symptomatic Uterine Fibroids [OP04-4D]

Transcervical Radiofrequency Ablation of Uterine Fibroids: US Experience From the SONATA Pivotal IDE Trial [22J]

Relugolix Combination Therapy Reduced Uterine Fibroid-Associated Pain in Two Phase 3 LIBERTY Studies [32B]

Health-related Quality of Life With Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial

LIBERTY: LONG-TERM EXTENSION STUDY DEMONSTRATING ONE-YEAR EFFICACY AND SAFETY OF RELUGOLIX COMBINATION THERAPY IN WOMEN WITH SYMPTOMATIC UTERINE FIBROIDS

A Benefit-Risk Review of Systemic Haemostatic Agents: Part 2: In Excessive or Heavy Menstrual Bleeding

Bleeding Patterns in Women With Uterine Fibroids Receiving Relugolix Combination Therapy Over 1 Year [A78]

Relugolix Combination Therapy Improves Uterine Fibroid Symptoms Independent of Fibroid Location [A77]

RELUGOLIX COMBINATION THERAPY SIGNIFICANTLY REDUCED MENSTRUAL BLOOD LOSS WITH FIRST TREATMENT CYCLE IN WOMEN WITH HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS: RESULTS FROM THE LIBERTY PHASE 3 PROGRAM

LIBERTY RANDOMIZED WITHDRAWAL STUDY: 2-YEAR EFFICACY AND SAFETY OF RELUGOLIX COMBINATION THERAPY IN WOMEN WITH HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS

EFFECTS OF RELUGOLIX COMBINATION THERAPY ON BONE MINERAL DENSITY THROUGH 2 YEARS IN WOMEN WITH HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS

Spherical Ball-Shaped Intrauterine Device Long-Acting Reversible Contraception: Post-marketing Pharmacovigilance Assessment

TIME TO MINIMAL OR NO PELVIC PAIN WITH RELUGOLIX COMBINATION THERAPY IN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN: RESULTS FROM THE SPIRIT PROGRAM

RELUGOLIX COMBINATION THERAPY IMPROVES UTERINE FIBROID-ASSOCIATED PAIN DURING MENSTRUAL AND NON-MENSTRUAL DAYS: RESULTS FROM THE LIBERTY PHASE 3 PROGRAM

Treatment of symptoms of uterine fibroids with relugolix combination therapy: efficacy and safety results from the phase 3 liberty 1 clinical trial

Ulipristal Acetate Impact on Fibroid Volume: Integrated Results From VENUS I and II [11Q]

Potential clinical applications of uterine artery occlusion

Treatment of uterine fibroid symptoms with relugolix combination therapy

Tranexamic Acid Treatment for Heavy Menstrual Bleeding: A Randomized Controlled Trial

Advantages wth Using the Levonorgestrel-Releasing Intrauterine System in Females with Hemostatic Disorders

How effective is elagolix treatment in women with fibroids and HMB?

Screening Tool for Bleeding Disorders in Women with Menorrhagia: Evaluation in a Prospective US Multi-Site Cohort

Assessment of Procedure Tolerability During Her Option Endometrial Ablation in Out-Patient Settings

A Multi-Site, Prospective Cross-Over Study of Intranasal Desmopressin and Oral Tranexamic Acid in Women with Menorrhagia and Abnormal Laboratory Hemostasis

Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks

Aktive Filter

Suchergebnisse filtern